Chemotherapie beim Harnblasenkarzinom: Update 2010

M. M. Heck; J. E. Gschwend; M. Retz

doi:10.1007/s00120-010-2380-y

Chemotherapie beim Harnblasenkarzinom: Update 2010

Translated title of the contribution: Update on chemotherapy for bladder cancer. Update 2010

M. M. Heck, J. E. Gschwend, M. Retz

Technical University of Munich

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

This review summarizes results of neoadjuvant and adjuvant trials for locally advanced bladder cancer as well as data on systemic chemotherapy for metastatic urothelial cancer.Increasing attention has been drawn to targeted cancer therapies in the treatment of urothelial cancer in recent years. In future, molecular profiling will play a major role as a means to tailor individual therapy.

Translated title of the contribution	Update on chemotherapy for bladder cancer. Update 2010
Original language	German
Pages (from-to)	1294-1300
Number of pages	7
Journal	Urologe - Ausgabe A
Volume	49
Issue number	10
DOIs	https://doi.org/10.1007/s00120-010-2380-y
State	Published - Oct 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00120-010-2380-y

Cite this

@article{8d61b37c8bdb45b99d4fba2760a36845,

title = "Chemotherapie beim Harnblasenkarzinom: Update 2010",

abstract = "This review summarizes results of neoadjuvant and adjuvant trials for locally advanced bladder cancer as well as data on systemic chemotherapy for metastatic urothelial cancer.Increasing attention has been drawn to targeted cancer therapies in the treatment of urothelial cancer in recent years. In future, molecular profiling will play a major role as a means to tailor individual therapy.",

keywords = "Bladder cancer, Chemotherapy, Targettherapy, Urothelial carcinoma",

author = "Heck, {M. M.} and Gschwend, {J. E.} and M. Retz",

year = "2010",

month = oct,

doi = "10.1007/s00120-010-2380-y",

language = "Deutsch",

volume = "49",

pages = "1294--1300",

journal = "Urologe - Ausgabe A",

issn = "0340-2592",

publisher = "Springer Medizin",

number = "10",

}

TY - JOUR

T1 - Chemotherapie beim Harnblasenkarzinom

T2 - Update 2010

AU - Heck, M. M.

AU - Gschwend, J. E.

AU - Retz, M.

PY - 2010/10

Y1 - 2010/10

N2 - This review summarizes results of neoadjuvant and adjuvant trials for locally advanced bladder cancer as well as data on systemic chemotherapy for metastatic urothelial cancer.Increasing attention has been drawn to targeted cancer therapies in the treatment of urothelial cancer in recent years. In future, molecular profiling will play a major role as a means to tailor individual therapy.

AB - This review summarizes results of neoadjuvant and adjuvant trials for locally advanced bladder cancer as well as data on systemic chemotherapy for metastatic urothelial cancer.Increasing attention has been drawn to targeted cancer therapies in the treatment of urothelial cancer in recent years. In future, molecular profiling will play a major role as a means to tailor individual therapy.

KW - Bladder cancer

KW - Chemotherapy

KW - Targettherapy

KW - Urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=77958464724&partnerID=8YFLogxK

U2 - 10.1007/s00120-010-2380-y

DO - 10.1007/s00120-010-2380-y

M3 - Übersichtsartikel

C2 - 20859610

AN - SCOPUS:77958464724

SN - 0340-2592

VL - 49

SP - 1294

EP - 1300

JO - Urologe - Ausgabe A

JF - Urologe - Ausgabe A

IS - 10

ER -

Chemotherapie beim Harnblasenkarzinom: Update 2010

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this